BMS ESMO Bristol Myers Squibb
Biotech

BMS reunites R&D divisions under Massacesi as Plenge departs

Bristol Myers Squibb is merging its research and development divisions under the leadership of Cristian Massacesi, M.D.
Nick Paul Taylor Nov 12, 2026 8:16am
akt health

Why scientific progress depends on knowing when to look again

Brought to you by Ipsen
Skyline Shanghai

Could we see 10 Chinese Big Pharmas within a decade?

Nov 11, 2026 9:00am
Advanced Analytics Help Reduce Control Animal Use While Preserving Scientific Rigor

How Virtual Control Groups Are Shaping Safety Studies

Brought to you by Charles River Laboratories
Blackstone

Pfizer taps Blackstone for $1.5B to pave path to GLP-1 launch

Nov 12, 2026 4:15am
Robert Kennedy Jr ARPA-H

ARPA-H bets $4.9 million on ibogaine to treat PTSD in veterans

Nov 12, 2026 2:56pm
More News
Fierce Pharma

FDA's CNPV speedy review program, CRL disclosures go quiet

Nov 12, 2026 11:26am

Vor pays RemeGen $10M for long-acting autoimmune drug successor

Nov 12, 2026 10:16am

Kyverna abandons next-gen CAR-T once touted as miv-cel follow-up

Nov 12, 2026 10:06am

Combo GCPR approach appears to reverse eye cancer signaling

Nov 12, 2026 10:00am